Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03332589 |
Title | E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS) |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Spirita Oncology, LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Arizona Cancer Center | Tucson | Arizona | 85724 | United States | Details |